The Efficacy of 18F-FDG PET in Diagnosing Alzheimer’s Disease in Patients with Memory Impairment

The Efficacy of 18F-FDG PET in Diagnosing Alzheimer's Disease in Patients with Memory Impairment

18F-FDG PET Reveals the Truth Behind Alzheimer’s Disease in Patients with Memory Impairment Currently, the diagnosis of Alzheimer’s Disease (AD) still faces many challenges, especially in patients initially diagnosed with memory impairment, where accurately distinguishing AD from other types of dementia is particularly important. In recent years, 18F-FDG PET, as an advanced molecular imaging technology, … Read more

Lancet Oncology Publishes! Efficacy and Safety of DS-8201 in Treating HER2-Positive Lung Cancer

Lancet Oncology Publishes! Efficacy and Safety of DS-8201 in Treating HER2-Positive Lung Cancer

Source: Professor Zhang Bo The activation mechanisms of the HER-2 gene include amplification, mutation, insertion, and protein overexpression. Although HER-2 is considered a driver gene in lung cancer, no targeted therapeutic drugs have been approved. Recently, Lancet Oncology published efficacy and safety data for the ADC drug DS-8201 targeting HER2 in patients with advanced NSCLC … Read more

The Efficacy of 18F-FDG PET in Diagnosing Alzheimer’s Disease in Patients with Memory Impairment

The Efficacy of 18F-FDG PET in Diagnosing Alzheimer's Disease in Patients with Memory Impairment

WeChat public platform followed by tens of thousands of nuclear medicine professionals 18F-FDG PET Reveals the Truth Behind Alzheimer’s Disease in Patients with Memory Impairment Currently, the diagnosis of Alzheimer’s Disease (AD) still faces many challenges, especially in patients initially diagnosed with memory impairment, where accurately distinguishing AD from other types of dementia is particularly … Read more